Clinical Trial Update: A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database

View source ↗

Summary

This completed real-world study assesses implementing the MASH patient care pathway in a Chinese population using the Meinian Health Check-up Database.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease
• Steatohepatitis

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH) | Status: COMPLETED